Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes

Clinical trial NCT05834868 · COMPLETED

Trial details

NCT number: NCT05834868
Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2022-05-06
Primary completion: 2024-12-10
Enrollment: 1040

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.